Article
Change in Roche Board of Directors
Dame DeAnne Julius (66), Member of the Board of Directors since 2002, has decided that she will not stand for re-election to the Board of Directors at the AGM in 2016.
PRESS RELEASE
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that Dame DeAnne Julius (66), Member of the Board of Directors since 2002, has decided that she will not stand for re-election to the Board of Directors at the AGM in 2016. The Board decided that Mrs Julie Brown (53), Chief Financial Officer of Smith & Nephew plc, will be nominated for election as a new member of the Board of Directors by the AGM in 2016.
Roche Chairman Christoph Franz: "As a Board member and as Chairman of the Audit Committee Dame DeAnne Julius has made important contributions to the success of Roche. On behalf of the Board I want to express my profound gratitude for her valuable services and wish her all the best for the future.” Christoph Franz added: "I am very pleased that with Julie Brown we are able to propose a leader with significant international commercial and financial experience in the healthcare industry to be elected as a new member of the Board.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
